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Background. The unprecedented increase in number of African refugees arriving in Europe is confronting clinicians and gen-
eral practitioners with the question of whether or not and how to screen migrants from endemic regions for Schistosoma mansoni 
infection.
Methods. We assessed the accuracy of 3 different diagnostic tests for S. mansoni infection (stool microscopy [samples prepared 
by sedimentation technique], serology, and point-of-care circulating cathodic antigen [POC-CCA] urine cassette test) in 107 newly 
arrived asymptomatic Eritrean refugees in Switzerland.
Result. Sixty-three study participants (59%) tested positive by at least 1 of the 3 methods. Thirty-seven participants (35%) were 
considered to have active schistosomiasis, either due to the detection of parasite eggs in stool and/or the presence of a concordant 
positive serology and urine POC-CCA test, which we consider to be a suitable surrogate marker of active infection. Of 23 micros-
copy-positive participants, 22 were positive by serology (95.7% sensitivity) and 21 were positive by the urine POC-CCA test (91.3% 
sensitivity). The combination of serology and urine POC-CCA testing detected all 23 microscopy-positive study participants (100% 
sensitivity).
Conclusions. With a sensitivity of 100% (95% confidence interval, 82.2%–100%), the combination of serology plus urine POC-
CCA testing appears to be the most sensitive screening option for asymptomatic S. mansoni infection in Eritrean refugees, compared 
with stool sedimentation microscopy.
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More than 250 million people are affected by schistosomiasis, a 
snail-borne parasitic disease with an estimated global burden of 
2.6 million disability-adjusted life years [1, 2]. Schistosomiasis 
is endemic in tropical and subtropical countries with >90% of 
cases concentrated in Africa [3, 4]. Recently, an outbreak of uro-
genital schistosomiasis occurred in Corsica, France, with >120 
confirmed cases among local people and tourists [5]. Although 
often asymptomatic, chronic long-standing infections may lead 
to significant morbidity and mortality.
In recent years, the unprecedented increase in number 
of African refugees arriving in Europe [6] is confronting 
clinicians and general practitioners with the question of 
whether or not to screen migrants from endemic regions for 
schistosomiasis [7, 8], especially as early recognition and 
treatment of asymptomatic patients offers the opportunity to 
prevent progression to symptomatic disease and considerable 
downstream sequelae [9].
The most widely used diagnostic tests for schistosomiasis 
are microscopy for the detection of parasite eggs in stool or 
urine, serological assays for the detection of Schistosoma-
specific antibodies in blood, and a commercially availa-
ble point-of-care (POC) test for the detection of circulating 
cathodic antigen (CCA) in urine [10]. As CCA is produced 
by live developing and adult worms only, its detection is, like 
the detection of eggs, considered to be indicative for active 
infection [11].
We assessed the accuracy of the aforementioned tests for 
the diagnosis of Schistosoma mansoni among asymptomatic 
Eritrean refugees who had arrived in Switzerland <24 months 
ago. Our objective was to identify a practical and accurate way 
of screening this special risk group for S. mansoni infection.
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METHODS
This diagnostic accuracy study was conducted as part of a 
cross-sectional survey, screening Eritrean refugees living 
in centers for asylum seekers in 2 cantons of northwestern 
Switzerland (Basel-Stadt and Basel-Landschaft) for the prev-
alence of infectious diseases (ie, intestinal parasitic infections, 
schistosomiasis, malaria, syphilis, human immunodeficiency 
virus, hepatitis B virus, and hepatitis C virus) and noncommu-
nicable health issues (ie, posttraumatic stress disorder, arterial 
hypertension, dyslipidemia, impaired glucose tolerance, and 
vitamin D deficiency). Using the cantonal refugee registries, all 
immigrants registered in these 2 cantons, aged ≥16 years who 
arrived from Eritrea within the past 24 months (n = 151), were 
contacted through invitation letter, followed up by a phone call 
(n  =  121). All asymptomatic Eritrean migrants fulfilling the 
inclusion criteria (n = 107) gave written informed consent and 
were enrolled (Figure  1). Asymptomatic was defined as cur-
rently not having any health issue the participant would con-
sider relevant enough to seek medical care.
Recruitment lasted from February to November 2016. After 
a medical interview and a clinical assessment, all participants 
underwent blood sampling, provided a urine sample, and 
received 2 stool containers to be filled on 2 different days with 
at least 10  g of stool. To maximize the yield of microscopic 
detection of helminth eggs, the full amount of stool of each 
sample was processed using a sedimentation technique (note: 
no quantitative assessment/egg count of the positive samples 
was conducted). The samples were suspended in 0.9% saline 
(NaCl) and passed through a double layer of gauze into a con-
ical sedimentation cup. The sedimentation cup was then filled 
with saline and left standing for an hour to let the heavier eggs 
settle on the bottom. After 1 hour, the supernatant was poured 
off and one-half of the sediment was examined under a micro-
scope. With the other half, an ether concentration method was 
performed [12, 13]. Each microscopic investigation was inde-
pendently read by 2 senior laboratory technicians, without 
having knowledge of the results of the other tests. The results 
of the microscopic examinations were pooled for each patient. 
Analysis of stool sediments was performed by well-trained 
and highly experienced staff from the Diagnostic Center of the 
Swiss Tropical and Public Health Institute (Swiss TPH), which 
serves as the national reference laboratory for human parasitic 
diseases in Switzerland.
Schistosoma-specific serology consisted of a panel of 3 
in-house assays (2 enzyme-linked immunosorbent assays 
[ELISAs] for the detection of antibodies against soluble egg-an-
tigen and antibodies against adult worm antigen, and 1 con-
firmatory immunofluorescent antibody test [IFAT]) with 
sections of adult worms used at the diagnostic center of Swiss 
TPH. These tests are comparable to commercial available tests 
using the same antigens [14]. The panel has been validated to 
have an overall sensitivity and specificity for S. mansoni infec-
tions of 98% and 96%, respectively [15, 16]. Infections by other 
Schistosoma species are detected as well with a slightly lower sen-
sitivity. The results of the ELISAs and the IFAT were interpreted 
according to the cutoffs previously determined by receiver 
operating characteristic analysis with 50 sera from healthy 
Swiss blood donors, 20 sera from S. mansoni-infected patients, 
and 120 sera of other helminth infections [15]. The final inter-
pretation for Schistosoma serology based on the results of all 3 
tests was reported according to the following criteria: “negative” 
if all tests were negative or if 2 tests were negative and 1 test was 
inconclusive, and “positive” if at least 2 of 3 tests were positive; 
all other combinations were reported as inconclusive.
Potential serological cross-reactivity among tissue para-
sites was assessed by parallel testing for Echinococcus species, 
Fasciola hepatica, Filaria species, Strongyloides stercoralis, 
Toxocara species, and Trichinella species–specific antibodies by 
routine ELISA testing at the Diagnostic Center of Swiss TPH.
Urine analysis included POC dipstick testing for protein, 
glucose, ketones, hemoglobin, bilirubin, urobilinogen, acetone, 
nitrite, leukocytes, and pH (Combur-9 test, Roche Diagnostics, 
Basel, Switzerland) and testing for the presence of Schistosoma-
specific CCA by using the immunochromatographic POC-CCA 
cassette test (Rapid Medical Diagnostics, Pretoria, South Africa). 
This test has been commercially available since 2008 and has, 
according to the manufacturer’s information, a sensitivity of 
100% if infection intensity is >400 eggs per gram of stool (EPG), 
decreasing to about 70% if infection intensity is low (<100 EPG). 
The specificity in nonendemic populations is reported to be 
around 95% [10]. POC-CCA test was performed according to the 
manufacturer’s instructions. Although the POC-CCA test is pri-
marily considered a qualitative test, we additionally assessed the Figure 1. Flow of recruitment of study participants.
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test results semiquantitatively. Any visible pink band on the POC-
CCA urine cassette test was documented according to its inten-
sity as “weak positive” or “clearly positive.” The absence of a band 
or a faint grayish background band was interpreted and docu-
mented as “negative.” POC-CCA test results were independently 
read by 2 laboratory technicians, without having knowledge of 
the results of the other tests. In case of discrepancies, a third per-
son was consulted to obtain a majority consensus. The presence 
of blood eosinophilia, defined as a cell count of ≥400 eosinophils/
µL, was assessed by manually performed differential blood count.
The sensitivity, specificity, and negative predictive value of the 
index tests serology and POC-CCA, as well as their combina-
tion, were compared to stool microscopy as reference standard. 
As we consider a conservative approach reasonable when rely-
ing on indirect parasitological tests and deciding on whether 
or not to treat a person, all “inconclusive” serology results were 
counted as “positive” in the analysis.
The correlation between the results of the 3 evaluated diag-
nostic test methods and the presence of blood eosinophilia and 
concomitant intestinal helminth infection, as well as the corre-
lation between POC-CCA test intensity and the results of serol-
ogy and stool microscopy and the presence of eosinophilia, was 
assessed by χ2 or Fisher’s exact test, as appropriate, using Stata 
version 13 software (StataCorp, College Station, Texas).
The study protocol was approved by the institutional research 
commission of Swiss TPH (reference number FK 120) and the 
ethics committee of Northwest and Central Switzerland (refer-
ence number EKNZ 2015–353).
RESULTS
A total of 107 asymptomatic Eritrean refugees (95 men, 12 
women; median age, 25  years [range, 19–29  years]) were 
enrolled into the study (Figure 1). Sixty-three of the 107 study 
participants (59%) tested positive for schistosomiasis by at least 
1 of the 3 performed diagnostic tests.
The results of the 3 diagnostic tests are shown in Figure 2. 
The concordance and discordance of the positive test results 
of the 3 different diagnostic tests are depicted in Figure  3. 
The sensitivity, specificity, and negative predictive value of 
serology, POC-CCA, and the combination of serology and 
POC-CCA compared to stool microscopy as the diagnostic 
reference standard are shown in Table  1. From the 23 par-
ticipants where Schistosoma eggs were detected by micros-
copy, 22 were positive in serology and 21 were positive in 
the POC-CCA test. The calculated sensitivity was 95.7% and 
91.3% for the serological test and the POC-CCA urine cas-
sette test, respectively. The combination of both tests detected 
all 23 samples, which were also positive in microscopy (100% 
sensitivity).
All Schistosoma eggs detected by stool microscopy were 
S. mansoni eggs. The only other helminth species detected by 
stool microscopy was Hymenolepis nana, with eggs found in 11 
of the 107 (10%) study participants.
Blood eosinophilia was present in 16 of the 107 (15%) par-
ticipants (Table 2). In 10 of these 16 cases, at least 1 of the 3 
schistosomiasis diagnostic tests was positive. In the remaining 
6 cases, no cause of blood eosinophilia was identified by any of 
the performed tests.
The correlation between the results of the 3 schistosomi-
asis diagnostic tests and the presence of blood eosinophilia 
as well as the presence of H.  nana infection is shown in 
Table 2. The correlation between the presence of blood eosin-
ophilia and H.  nana infection is shown in Table  3. Table  4 
shows the correlation between the intensity of POC-CCA 
test results and serology and microscopy results as well as the 
presence of blood eosinophilia. Table 5 shows the kappa (κ) 
Figure 2. Number of complete sample sets and results of reference standard and index tests. Abbreviation: POC-CCA, point-of-care circulating cathodic antigen.
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analysis, assessing the degree of agreement among performed 
diagnostic tests.
The parallel testing of all 107 serum samples for potential 
cross-reactivity to other concomitantly or previously present 
tissue-invasive helminth infections did not yield any positive 
result for the tested helminth infections (data not shown). The 
urine dipstick test for protein, glucose, ketones, hemoglobin, 
bilirubin, urobilinogen, acetone, nitrite, leukocytes, and pH was 
unremarkable in all 107 cases.
DISCUSSION
Diagnosing schistosomiasis can be challenging as the validity 
and reliability of currently available diagnostic tests are, espe-
cially if used separately, limited [17]. The demonstration of 
eggs in stool or urine by microscopy can be difficult as the day-
to-day variation of egg excretion may be considerable and the 
detection of eggs in individuals with a low worm burden may 
even be impossible [18, 19]. Although not perfect, microscopy 
is generally considered the “gold standard” reference method 
when evaluating the accuracy of diagnostic assays for schistoso-
miasis. In this regard, it deserves to be highlighted that our used 
stool preparation technique, using at least 10 g of stool, is con-
siderably more sensitive than the widely used Kato-Katz tech-
nique. Indeed, a single Kato-Katz thick smear only examines 
41.7 mg of stool [20] and, hence, the total volume of duplicate or 
Table  1. Sensitivity, Specificity, and Negative Predictive Value of 
Serology, Point-of-Care Circulating Cathodic Antigen (POC-CCA), and the 
Combination of Serology and POC-CCA, Compared to Stool Microscopy as 





Serology Positiveb 22 32
Negative 1 52
Sensitivity 95.7% (95% CI, 76.0%–99.8%)
Specificity 61.9% (95% CI, 50.6%–72.1%)
NPV 98.1% (95% CI, 88.6%–99.9%)
POC-CCA Positive 21 22
Negative 2 62
Sensitivity 91.3% (95% CI, 70.5%–98.5%)
Specificity 73.8% (95% CI, 62.9%–82.5%)





Sensitivity 100% (95% CI, 82.2%–100%)
Specificity 52.4% (95% CI, 41.3%–63.3%)
NPV 100% (95% CI, 90.0%–100%)
Abbreviations: CI, confidence interval; NPV, negative predictive value; POC-CCA, point-of-
care circulating cathodic antigen.
aMicroscopy of sediment of 2 stool samples (≥10 g stool/sample).
b“Inconclusive” serology results were counted as positive.
Table 2. Correlation Between the Results of 3 Different Schistosoma mansoni Screening Methods and the Presence of Blood Eosinophilia (n = 16) and 





P ValuePresent Absent Present Absent
Serology Positivec 10 44 .297 6 48 .775a
Negative 6 47 5 48
POC-CCA Positive 9 34 .155 5 37 .657a
Negative 7 57 6 59
Serology + POC-CCAd Positivec 9 25 .023 8 55 .519b
Negative 7 66 3 41
Stool microscopy Positive 8 15 .003 3 20 NA
Negative 8 76 8 76
Abbreviations: NA, not applicable; POC-CCA, point-of-care circulating cathodic antigen.
aχ2 test.
bFisher’s exact test.
c“Inconclusive” serology results were counted as positive.
dConcordant positive test results with both methods.
Figure  3. Concordance and discordance of positive screening results for 
Schistosoma mansoni in 63 of 107 tested asymptomatic Eritrean refugees, strati-
fied by 3 diagnostic tests. Abbreviation: POC-CCA, point-of-care circulating cathodic 
antigen.
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triplicate Kato-Katz thick smears is still 2 orders of magnitude 
lower than what has been examined in the current study. Yet, 
multiple Kato-Katz thick smears are frequently utilized as ref-
erence standard in studies evaluating the accuracy of diagnos-
tic tests in S. mansoni and soil-transmitted helminth infections 
[21, 22]. A limitation of the applied sedimentation method 
compared to Kato-Katz is that Kato-Katz allows estimating the 
intensity of infection, as expressed by EPG.
A limitation of serology is that, compared to microscopy 
and antigen detection, Schistosoma-specific antibodies may 
remain detectable for several years after successful medical 
treatment or the natural death of the parasite, and that such 
“serological scars” cannot be differentiated from active infec-
tion [14]. In addition, cross-reactivity of assays in the case of 
previous or concomitant infection with other parasites may be 
a problem. Our performed serological screening for other tis-
sue-invasive helminth infections (Echinococcus species, Fasciola 
hepatica, Filaria species, S.  stercoralis, Toxocara species, and 
Trichinella species) did not reveal any evidence of false-positive 
Schistosoma serology or POC-CCA testing due to the presence 
of these helminth infections. There was no evidence that intes-
tinal H. nana infection may lead to false-positive Schistosoma 
serology (Table 2).
The downside of the POC-CCA test is that false-positive 
results have been described, in particular if traces in band 
intensity are classified as being positive [23]. False-positive 
results also seem to be associated with urinary tract infection, 
hematuria, and pregnancy [10, 24]. This is primarily attributed 
to the fact that the polysaccharide structure of CCA contains 
repeating units of Lewis-X trisaccharide, a molecule that is a 
common epitope on human cells (especially anti-inflammatory 
cells like granulocytes) [23]. There was no evidence that intes-
tinal H.  nana infection may lead to false-positive POC-CCA 
results (Table 2).
Owing to the aforementioned limitations, a currently unre-
solved issue is how to interpret test results if only serology or 
only POC-CCA testing is positive. In this regard, the 3 cases 
in which eggs were found by microscopy even though serol-
ogy and POC-CCA results were discordant (Figure  3) war-
rants attention. These cases illustrate that discordant serology 
and POC-CCA results should not generally be discarded as 
false-negative. Nevertheless, it is conceivable that some of the 
cases which tested positive by serology depict “serological scars” 
and that some of the cases which only tested positive by POC-
CCA depict false-positive results.
As we observed a considerable variability in intensity of the 
visible band of the POC-CCA test strip, we performed a sub-
group analysis and found that clearly positive POC-CCA test 
results show a statistically significant correlation to the micro-
scopic detection of eggs (Table 4). For samples being positive in 
1 or >1 test, the majority of samples with positive serology or 
microscopy are also clearly positive in POC-CCA, 76% (22/29) 
Table 3. Correlation Between the Presence of Blood Eosinophilia and the 





Hymenolepis nana Positive 1 10 .332
Negative 15 81
aFisher’s exact test.
Table 4. Correlation Between the Intensity of Point-of-Care Circulating 
Cathodic Antigen Results and Serology and Microscopy Results as Well 








Serology Positive 22 7 .199
Inconclusive 2 3
Negative 5 4
Microscopy Positive 18 3 .022
Negative 11 11
Eosinophilia Present 7 1 1.0
Absent 11 2
Abbreviation: POC-CCA, point-of-care circulating cathodic antigen.
aFisher’s exact test.
Table 5. Assessing the Degree of Agreement Among Performed Diagnostic Tests by Kappa Coefficient
Diagnostic Test Result
Stool Microscopy Kappa
Positive Negative κ Coefficient SE 95% CI Interpretationa
Serology Positive 22 32 0.297 0.073 .24–.53 Fair
Negative 1 52
POC-CCA Positive 21 22 0.155 0.082 .34–.66 Moderate
Negative 2 62
Serology and/or POC-CCA Positive 23 40 0.023 0.062 .20–.44 Fair
Negative 0 44
Abbreviations: CI, confidence interval; POC-CCA, point-of-care circulating cathodic antigen; SE, standard error.
aInterpretation of κ coefficient, reflecting the degree of agreement among diagnostic tests: ≤0, chance/less than chance; 0.01–0.20, slight; 0.21–0.40, fair; 0.41–0.60, moderate; 0.61–0.80, 
substantial; 0.81–0.99, almost perfect.
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and 86% (18/21), respectively. In contrast, inconclusive or neg-
ative serology samples or negative microscopy samples yield in 
approximately 50% clearly positive and in approximately 50% 
weakly positive POC-CCA result, most likely reflecting the 
lower intensity of infection. This finding suggests that weakly 
positive POC-CCA test results largely represent infections with 
low egg output not readily detectable by microscopy. This obser-
vation is supported by data from a recent field study in Tanzania, 
where digital software-supported reading of the POC-CCA cas-
sette test revealed an improved differentiation between weakly 
positive “true” bands and nonspecific traces, thereby improving 
the correlation between test intensity and egg count [25].
In our study, the ratio of POC-CCA–positive cases to micros-
copy-positive cases (43 to 23)  is 1.9 and thus in line with a 
recently published systematic review concluding that below 
50% prevalence by Kato-Katz, the prevalence by POC-CCA 
assay is between 1.5- and 6-fold higher [26]. The observation 
that the ratio in our study is at the lower end of the reported 
range may reflect the comparable high sensitivity of our stool 
microscopy method. The ratio of serology-positive and incon-
clusive cases to microscopy-positive cases (54 to 23) is 2.4 and 
most likely reflects the anticipated high prevalence of “serologi-
cal scars” in a high-endemicity population [4].
An interesting observation is that the presence of blood 
eosinophilia shows a statistically significant correlation with 
the detection of Schistosoma eggs by microscopy, whereas no 
correlation between blood eosinophilia and positive POC-CCA 
testing is seen (Table  2). Considering that blood eosinophilia 
is clinically regarded as a supportive surrogate marker for the 
presence of an active parasite infection, the observation may be 
interpreted in 2 ways. It may suggest that blood eosinophilia is 
only seen in the presence of a high parasite burden, resulting in 
high egg excretion and thus in cases more reliably identified by 
microscopy. Consequently, it could be argued that POC-CCA 
testing may be capable of detecting cases with a low parasite 
burden not leading to blood eosinophilia. However, the lack 
of correlation between blood eosinophilia and POC-CCA 
could also be interpreted as an indirect surrogate marker for 
false-positive results and might reflect the test’s limited speci-
ficity. The lack of correlation between blood eosinophilia and 
positive serology is anticipated in a high-endemicity population 
due to the high prevalence of “serological scars” [4].
Despite the shortcomings of indirect diagnostic assays, we 
considered it reasonable to assume that, owing to the test assays’ 
different operating modes, cases that concordantly tested pos-
itive by serology and POC-CCA depict true cases of active 
infection and that concordant false-positive results are rather 
unlikely. This assumption is also supported by the observed sta-
tistically significant correlation between blood eosinophilia and 
concordant positive results of serology and POC-CCA testing 
(Table 2). An auxiliary finding worth mentioning is that we did 
not find any correlation between blood eosinophilia and the 
presence of H. nana infection, although a relationship between 
this intestinal cestode infection and blood eosinophilia is fre-
quently referenced in the literature [27, 28].
A limitation of our study worth mentioning is that we did not 
perform urine microscopy to rule out S.  haematobium infec-
tion, which could have possibly led to positive serology as well 
as positive POC-CCA results. However, as no microhematuria 
has been detected in any of the urine samples and considering 
that a recent review concluded that in urogenital schistosomi-
asis CCA test performance is inferior to urine strips for detect-
ing blood [29], we do not consider this issue to possibly have 
impacted the POC-CCA results of our study.
In conclusion, our data suggest that the combination of 
serology and POC-CCA is superior to stool microscopy when 
screening asymptomatic Eritrean refugees for S. mansoni infec-
tion and that stool microscopy does not contribute to diagnos-
tic accuracy. The presence of blood eosinophilia is supportive of 
active schistosomiasis, but its absence does not exclude active 
infection. All cases having a concordant positive serology and 
POC-CCA test should be considered to have active S. mansoni 
infection. However, considering that untreated chronic schis-
tosomiasis may lead to significant morbidity downstream and 
considering that treatment with praziquantel is generally well 
tolerated and inexpensive, the threshold to treat any positive 
test result should be very low. This conclusion holds, even 
though some patients may receive unnecessary treatment due 
to false-positive serology or POC-CCA results.
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